Physician profile
Christopher C Harrod
NPI 1285760694
$3,029,053.80
in general payments reported to CMS, 2019-2025
33 companies · $406K in 2025
The $406K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $711K · 2020: $296K · 2021: $307K · 2022: $433K · 2023: $125K · 2024: $750K · 2025: $406K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.2M · Consulting Fee: $21K · Travel and Lodging: $9,214 · Food and Beverage: $2,332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,249,381.49 |
| Consulting Fee | $20,875.00 |
| Travel and Lodging | $9,214.20 |
| Food and Beverage | $2,331.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,459,088.42 | 2019-2025 | Yukon Oct Spinal System, Cayman Plate System |
| East Louisiana Surgical Services, LLC | $420,000.00 | 2019 | |
| Curiteva, INC. | $326,127.81 | 2020-2025 | |
| Innovasis INC | $311,836.62 | 2019-2025 | Lxha, Lxha, Buttress Plate |
| Vb Spine LLC | $197,134.58 | 2025 | Yukon Oct Spinal System, Capri Corpectomy Cage System |
| Integrity Implants INC. | $159,695.38 | 2019-2022 | Flarehawk |
| Integrity Implants INC. Dba Accelus | $111,679.39 | 2023-2024 | Flarehawk |
| Alphatec Spine, INC | $26,820.32 | 2019-2024 | Other - Miscellaneous, Plx, Identiti |
| Depuy Synthes Products, INC. | $7,775.72 | 2022 | |
| Osteocentric Technologies, INC. | $5,250.00 | 2023-2024 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Providence Medical Technology, INC. | $748.36 | 2021-2025 | |
| Boston Scientific Corporation | $590.79 | 2020-2025 | General - Pain Management |
| Abbott Laboratories | $454.40 | 2020-2024 | Proclaim |
| Spine Wave, INC. | $429.29 | 2024-2025 | Spinal Implant, Ni-Lock Anterior Cervical Plate System |
| Depuy Synthes Sales INC. | $207.56 | 2019-2024 | Fibergraft Bg Morsels, Symphony, Vivigen Mis Delivery System |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $149.64 | 2025 | Unid_pass |
| Si-Bone, INC. | $147.86 | 2023 | |
| Alon Medical Technology | $136.95 | 2023-2025 | |
| Saluda Medical Americas, INC. | $126.42 | 2025 | Evoke |
| Medical Device Business Services, INC. | $115.34 | 2022 | |
| Carlsmed, INC. | $106.59 | 2025 | Aprevo |
| Pacira Pharmaceuticals Incorporated | $94.58 | 2019-2025 | Exparel, Iovera |
| Bioventus LLC | $93.84 | 2021-2023 | |
| Globus Medical, INC. | $47.57 | 2023-2025 | Creo, Alif Instruments (Universal) |
| Medtronic USA, INC. | $41.83 | 2019-2020 | |
| Sanara Medtech INC. | $40.11 | 2024-2025 | Celleraterx, Biasurge |
| Orthofix Medical, INC. | $20.93 | 2023 | Trinity Elite |
| Spineology INC. | $19.61 | 2024 | Optimesh Expandable Interbody Fusion System |
| Relievant Medsystems, INC. | $19.28 | 2022 | |
| Pfizer INC. | $18.78 | 2020 | |
| Nevro Corp. | $18.52 | 2019 | |
| Nalu Medical, INC. | $17.31 | 2024 | Nalu Neurostimulation System |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$47,815.03 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Harrod listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.